Certified by Founder Lodge
Alpha-9 Oncology
United States - Boston, Massachusetts
START UP
1 Disclosed Funding Rounds $175,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Alpha-9 Oncology is a clinical stage, radiopharmaceutical company developing differentiated and highly targeted radiopharmaceuticals with the potential to meaningfully improve the treatment o
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 24 ,2024 | Series C | $175,000,000 |
Digitalis Ventures
Nextech Invest
RA Capital Management, L.P.
Janus Henderson Investors
Longitude Capital
Lumira Ventures
Samsara BioCapital
Ascenta Capital
Frazier Life Sciences
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
TG0 | $5,619,170 | (Dec 20, 2024)
Double(US) | $3,900,000 | (Dec 20, 2024)
Mindgard | $8,000,000 | (Dec 20, 2024)
Hauler Hero | $10,000,000 | (Dec 20, 2024)
LeapFinancial | $3,500,000 | (Dec 20, 2024)
